Argomenti e Notizie
sull'Osteoporosi
con raccolte
bibliografiche su
PubMed Logo
a cura del
Dott. C.Tarozzi
Bologna
Anno 24°
Num. 143
Recens. 2855
Aderiamo allo standard HONcode per l'affidabilitŗ dell'informazione medica questo sito aderisce fin dal 2004 allo standard HONcode per l'affidabilità dell'informazione medica. Verifica qui.
Rassegna - Alimenti e Calcio - Questionari - T-Score - Valore di un Test - Calcolatori - Contatti - Digitalia - Radioactivity
Ricerca nell'archivio di questo sito...
 ?  
Nuova bibliografia selezionata fino al mese di ottobre 2019 (recensioni 31.75) Ordina per Autore - Titolo - Rivista
Kong M, Zhou C, Zhu K, Zhang Y, Song M, Zhang H, Tu Q, Ma X.
12-Month Teriparatide Treatment Reduces New Vertebral Compression Fractures Incidence And Back Pain And Improves Quality Of Life After Percutaneous Kyphoplasty In Osteoporotic Women.
Clin Interv Aging. 2019 Oct 1;14:1693-1703.

Fabiano A, Piras AM, Calderone V, Testai L, Flori L, Puppi D, Chiellini F, Zambito Y.
A New Calcium Oral Controlled-Release System Based on Zeolite for Prevention of Osteoporosis.
Nutrients. 2019 Oct 15;11(10). pii: E2467.

Bokrantz T, Schiöler L, Boström KB, Kahan T, Mellström D, Ljungman C, Hjerpe P, Hasselström J, Manhem K.
Antihypertensive drug classes and the risk of hip fracture: results from the Swedish primary care cardiovascular database.
J Hypertens. 2019 Sep 19. PMID: 31568060.

Ofotokun I, Collins LF, Titanji K, Foster A, Moran CA, Sheth AN, Lahiri CD, Lennox JL, Ward L, Easley KA, Weitzmann MN.
Antiretroviral Therapy-induced Bone Loss is Durably Suppressed by a Single Dose of Zoledronic Acid in Treatment-naÔve Persons with HIV Infection: a Phase IIB Trial.
Clin Infect Dis. 2019 Oct 17.

Lorenzo-Pouso AI, Pérez-Sayáns M, Chamorro-Petronacci C, Gándara-Vila P,López-Jornet P, Carballo J, García-García A.
Association between periodontitis and medication-related osteonecrosis of the jaw: a systematic review and meta-analysis.
J Oral Pathol Med. 2019 Oct 12.

Takahashi M, Ozaki Y, Kizawa R, Masuda J, Sakamaki K, Kinowaki K, Umezu T, Kondoh C, Tanabe Y, Tamura N, Miura Y, Shigekawa T, Kawabata H, Baba N, Iguchi H,Takano T.
Atypical femoral fracture in patients with bone metastasis receiving denosumab therapy: a retrospective study and systematic review.
BMC Cancer. 2019 Oct 22;19(1):980.

Morse LR, Biering-Soerensen F, Carbone LD, Cervinka T, Cirnigliaro CM, Johnston TM, Liu N, Troy KL, Weaver FM, Shuhart C, Craven BC.
Bone Mineral Density Testing in Spinal Cord Injury: The 2019 ISCD Official Positions.
J Clin Densitom. 2019 Aug 3. pii: S1094-6950(19)30173-8.

Kendler DL, Bone HG, Massari F, Gielen E, Palacios S, Maddox J, Yan C, Yue S, Dinavahi RV, Libanati C, Grauer A.
Bone mineral density gains with a second 12-month course of romosozumab therapy following placebo or denosumab.
Osteoporos Int. 2019 Oct 18.

Cai S, Yu H, Li Y, He X, Yan L, Huang X, Wang P.
Bone mineral density measurement combined with vertebral fracture assessment increases diagnosis of osteoporosis in postmenopausal women.
Skeletal Radiol. 2019 Jul 27.

Kelly JJ, Garapati SS.
Combination therapies in the treatment of osteoporosis.
Curr Opin Endocrinol Diabetes Obes. 2019 Oct 11.

Azami A, Anari H, Iranparvar M, Azizi A, Habibzadeh A.
Comparison of Bone Mineral Densitometry at 2 Sites Versus 3 Sites in Patients Suspicious for Osteoporosis.
Clin Med Insights Arthritis Musculoskelet Disord. 2019 May 14;12:1179544119849017

Yanbeiy ZA, Hansen KE.
Denosumab in the treatment of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis.
Drug Des Devel Ther. 2019 Aug 14;13:2843-2852.

Divan V, Rao SD, Dhaliwal R.
Detection and management of atypical femur fractures.
Curr Opin Endocrinol Diabetes Obes. 2019 Oct 5.

Xu XM, Li N, Li K, Li XY, Zhang P, Xuan YJ, Cheng XG.
Discordance in diagnosis of osteoporosis by quantitative computed tomography and dual-energy X-ray absorptiometry in Chinese elderly men.
J Orthop Translat. 2018 Dec 21;18:59-64.

Gonzalo-Encabo P, McNeil J, Boyne DJ, Courneya KS, Friedenreich CM.
Dose-response effects of exercise on bone mineral density and content in ost-menopausal women.
Scand J Med Sci Sports. 2019 Aug;29(8):1121-1129.

Burt LA, Billington EO, Rose MS, Raymond DA, Hanley DA, Boyd SK.
Effect of High-Dose Vitamin D Supplementation on Volumetric Bone Density and Bone Strength: A Randomized Clinical Trial.
JAMA. 2019 Aug 27;322(8):736-745.

Ding X, Yang L, Hu Y, Yu J, Tang Y, Luo D, Zheng L.
Effect of local application of biphosphonates on improving peri-implant osseointegration in type-2 diabetic osteoporosis.
Am J Transl Res. 2019 Sep 15;11(9):5417-5437.

Khan AA, Farhad A, Siddiqui PQR, Ansari B.
Effects of osteoanabolic exercises on bone mineral density of osteoporotic females: A randomized controlled trial.
Int J Health Sci (Qassim). 2019 Jan-Feb;13(1):9-13.

Qian X, Li Z, Ruan G, Tu C, Ding W.
Efficacy and toxicity of extended aromatase inhibitors after adjuvant aromatase inhibitors-containing therapy for hormone-receptor-positive breast cancer: a literature-based meta-analysis of randomized trials.
Breast Cancer Res Treat. 2019 Oct 12.

Pineda-Moncusí M, Garcia-Giralt N, Diez-Perez A, Servitja S, Tusquets I, Prieto-Alhambra D, Nogués X.
Increased Fracture Risk in Women Treated with Aromatase Inhibitors versus Tamoxifen: Beneficial Effect of Bisphosphonates.
J Bone Miner Res. 2019 Oct 9.

Hsu E.
Paget's disease of bone: updates for clinicians.
Curr Opin Endocrinol Diabetes Obes. 2019 Sep 30.

Zullo AR, Sorial MN, Lee Y, Lary CW, Kiel DP, Berry SD.
Predictors of Hip Fracture Despite Treatment with Bisphosphonates among Frail Older Adults.
J Am Geriatr Soc. 2019 Oct 3.

Shayganfar A, Khodayi M, Ebrahimian S, Tabrizi Z.
Quantitative diagnosis of osteoporosis using lumbar spine signal intensity in magnetic resonance imaging.
Br J Radiol. 2019 May;92(1097):20180774.

Smith AD.
Screening of Bone Density at CT: An Overlooked Opportunity.
Radiology. 2019 May;291(2):368-369.

Kotwal A, Hurtado MD, Sfeir JG, Wermers RA.
TRANSIENT OSTEOPOROSIS: CLINICAL SPECTRUM IN ADULTS AND ASSOCIATED RISK FACTORS.
Endocr Pract. 2019 Jul;25(7):648-656.

Shimodan S, Sato D, Takahashi K, Nakamura Y, Hyakkan R, Watanabe T, Hishimura R, Ota M, Shimizu H, Hojo Y, Hasegawa Y, Chubachi T, Yasui K, Tsujimoto T, Tsukuda Y, Asano T, Takahashi D, Takahata M, Iwasaki N, Shimizu T.
Ten years change in post-fracture care for hip fracture patients.
J Bone Miner Metab. 2019 Oct 3.

Mikula AL, Puffer RC, Jeor JDS, Bernatz JT, Fogelson JL, Larson AN, Nassr A, Sebastian AS, Freedman BA, Currier BL, Bydon M, Yaszemski MJ, Anderson PA, Elder BD.
Teriparatide treatment increases Hounsfield units in the lumbar spine out of proportion to DEXA changes.
J Neurosurg Spine. 2019 Oct 18:1-6.

Qutbi M, Salek A, Soltanshahi M, Ajdari SE, Asli IN.
The impact of nonstandard hip rotation on densitometric results of hip regions and potential misclassification of diagnosis.
Arch Osteoporos. 2019 Aug 1;14(1):86.

Minisola S, Cipriani C, Grotta GD, Colangelo L, Occhiuto M, Biondi P, Sonato C, Vigna E, Cilli M, Pepe J.
Update on the safety and efficacy of teriparatide in the treatment of osteoporosis.
Ther Adv Musculoskelet Dis. 2019 Oct 5;11:1759720X19877994.

Gonzalez AAL, Grases F, Mari B, Tomas-Salva M, Rodriguez A.
Urinary phytate concentration and risk of fracture determined by the FRAX index in a group of postmenopausal women.
Turk J Med Sci. 2019 Apr 18;49(2):458-463.

Buisset C, Demarquet L, Raynal M, Busby H, Nominé-Criqui C, Brunaud L.
When a Pathological Forearm Fracture Led to Explore the Neck: About a Case.
Head Neck Pathol. 2019 Oct 12. doi: 10.1007/s12105-019-01085-3.

Demidko LS, Rudenko VI, Fadeev VV, Demidko YL, Amosov AV, Kuzmicheva GM, Grigoryan VA, Enikeev ME, Amosova MV.
[Inluence of osteoporosis and its causative factors on the prevention of recurrence of urinary stone disease].
Urologiia. 2019 Sep;(4):26-31. Russian.

(Vers. 2.1)  Modificato il 24-10-2019
http://www.tarozzi.net   
questo sito aderisce ai principi HONCODE    disclaimer